Melioidosis Vaccine Symposium: "Moving from animal models to man", Feb 2019
Discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans
Melioidosis Vaccine Symposium: Moving from animal models to man
26 February 2019, 10:00am to 10:00am
Discussing the roadmap to first-in-man melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans
Member Resources
Members Directory
Membership Benefits
Metabolic reprogramming of skin microenvironment for improved BCG vaccine efficacy
Titular Prof Francisco Javier Sánchez-García, Instituto Politécnico Nacional, Mexico
MH Samorita Medical College
Bangladesh
Millicent Lamptey Poster 2023
Millicent Lamptey Poster 2024
Millicent Naa Koshie Lamptey Poster 2025
Ministry of Health and Family Welfare
India
Mirvat Surakhy
Looking for an ECR LMIC partner interested in collaborating on new projects to further characterise the BCG-induced humoral response.
Modelling the impact of a transmission blocking vaccine against leishmaniasis on sand fly vectorial capacity
Dr Matthew Rogers, LSHTM, UK
Modibbo Adamawa State University Teaching Hospital
Nigeria
Mohamed Osman 2019
Mohammad Uddin Poster 2025
Monitoring and Addressing Challenging Risks, Rumours and Reputations Across the GCRF Vaccinology Networks
In 2018 three of the GCRF Vaccinology Networks, VALIDATE, HIC-VAC and IMPRINT, joined together to co-fund an 18-month long project based at the Vaccine Confidence Project at LSHTM.
Monthly Update, July 2023
07 July 2023
Monthly Update, November 2023
03 November 2023
Monthly Update, October 2023
06 October 2023
Moredun Research Institute
United Kingdom
Mount Kenya University
Kenya
MRC Developmental Pathway Funding Scheme
4 March 2026, 4:00pm to 4:00pm
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions.
MRC Infections and Immunity New Investigator
Apply for funding to research infections and immunity take the next step towards becoming an independent principal investigator.